Juan C. Ramos
Hematology Oncology | Hematology
1475 Northwest 12th Avenue
Floor 2
Miami, FL 33136
Floor 2
Miami, FL 33136
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Adult T-Cell Leukemia/Lymphoma and Targeted Maternal Screening.
Journal: JAMA oncology
Published: April 30, 2026
Distribution of adult T-cell leukaemia/lymphoma subtypes and survival outcomes across geographical regions: An international retrospective cohort study.
Journal: British journal of haematology
Published: January 19, 2026
Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization.
Journal: American journal of clinical pathology
Published: November 12, 2025
Epidemiology of adult T-cell leukemia/lymphoma (ATL) in people living with HTLV-1: A 30-year study in Peru.
Journal: PLoS neglected tropical diseases
Published: September 08, 2025
Population Genomics of Macrophomina spp. Reveals Cryptic Host Specialization and Evidence for Meiotic Recombination.
Journal: Molecular plant-microbe interactions : MPMI
Published: June 24, 2025
Integrative Functional Genomics Analysis of Kaposi Sarcoma Cohorts.
Journal: Research square
Published: March 31, 2025
Integrative functional genomics analysis of Kaposi sarcoma cohorts.
Journal: Scientific reports
Published: March 18, 2025
Transcriptome and microbiome-immune changes across preinvasive and invasive anal cancer lesions.
Journal: JCI insight
Published: March 12, 2024
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations.
Journal: Haematologica
Published: February 08, 2024
Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiation.
Journal: Journal of medical virology
Published: January 04, 2024
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.
Journal: Cancer
Published: July 30, 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
Journal: The Lancet. Haematology
Published: January 24, 2023
Last Updated: 09/26/2026